BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ulrich H, Pillat MM, Tárnok A. Dengue Fever, COVID-19 (SARS-CoV-2), and Antibody-Dependent Enhancement (ADE): A Perspective. Cytometry A 2020;97:662-7. [PMID: 32506725 DOI: 10.1002/cyto.a.24047] [Cited by in Crossref: 64] [Cited by in F6Publishing: 65] [Article Influence: 21.3] [Reference Citation Analysis]
Number Citing Articles
1 Dalugama C, Seneviratne SL. Dengue and COVID-19 co-infections: an important consideration in the tropics. Transactions of The Royal Society of Tropical Medicine and Hygiene 2022. [DOI: 10.1093/trstmh/trac114] [Reference Citation Analysis]
2 Balasubramani S. COVID-19 Antibodies as Predictor of Severe Dengue among Hospitalized Children with Dengue Illness in the Post-third-wave Period of COVID-19 Infection in India. JAPI 2022;70:45-48. [DOI: 10.5005/japi-11001-0092] [Reference Citation Analysis]
3 Avila-bonilla RG, Salas-benito JS. Interactions of host miRNAs in the flavivirus 3´UTR genome: From bioinformatics predictions to practical approaches. Front Cell Infect Microbiol 2022;12:976843. [DOI: 10.3389/fcimb.2022.976843] [Reference Citation Analysis]
4 Oladipo HJ, Rabiu I, Tajudeen YA. Dengue virus and SARS-CoV-2 Co-infection dynamics: An emerging threat among African countries. Annals of Medicine and Surgery 2022;82:104398. [DOI: 10.1016/j.amsu.2022.104398] [Reference Citation Analysis]
5 Gan L, Chen Y, Tan J, Wang X, Zhang D. Does potential antibody-dependent enhancement occur during SARS-CoV-2 infection after natural infection or vaccination? A meta-analysis. BMC Infect Dis 2022;22:742. [PMID: 36123623 DOI: 10.1186/s12879-022-07735-2] [Reference Citation Analysis]
6 Luu MN, Alhady STM, Nguyen Tran MD, Truong LV, Qarawi A, Venkatesh U, Tiwari R, Rocha ICN, Minh LHN, Ravikulan R, Dumre SP, Giang HTN, Pavlenko D, Ali FY, Le BD, Karimzadeh S, Bhandari P, Shah J, Abdul Aziz JM, Huy NT; and the TMGH COVID-19 Collaborators. Evaluation of risk factors associated with SARS-CoV-2 transmission. Current Medical Research and Opinion. [DOI: 10.1080/03007995.2022.2125258] [Reference Citation Analysis]
7 Singhal P, Rawat A, Sharma S, Sharma AK, Jat KS, Agarwal S, Samdani S, Agarwal S, Sharma MP, Bhandari S. Invasive Fungal Infections in Dengue Recovered Patients: A New Phenomenon in the Covid-19 Era. Indian J Otolaryngol Head Neck Surg 2022. [DOI: 10.1007/s12070-022-03152-8] [Reference Citation Analysis]
8 Cheng Y, Chao C, Lai Y, Hsieh K, Wang J, Wan S, Huang H, Chuang Y, Chuang W, Yeh T. Antibodies against the SARS-CoV-2 S1-RBD cross-react with dengue virus and hinder dengue pathogenesis. Front Immunol 2022;13:941923. [DOI: 10.3389/fimmu.2022.941923] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Yang X, Zhang X, Zhao X, Yuan M, Zhang K, Dai J, Guan X, Qiu H, Li Y. Antibody-Dependent Enhancement: ″Evil″ Antibodies Favorable for Viral Infections. Viruses 2022;14:1739. [DOI: 10.3390/v14081739] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Huang XY, Yang LJ, Hu X, Zhang XX, Gu X, Du LJ, He ZY, Gu XJ. Elevated levels of fructosamine are independently associated with SARS-CoV-2 reinfection: A 12-mo follow-up study. World J Diabetes 2022; 13(7): 543-552 [DOI: 10.4239/wjd.v13.i7.543] [Reference Citation Analysis]
11 Trivedi S, Chakravarty A. Neurological Complications of Dengue Fever. Curr Neurol Neurosci Rep 2022. [PMID: 35727463 DOI: 10.1007/s11910-022-01213-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Wang J, Dong W. COVID-19: the possibility, ways, mechanisms, and interruptions of mother-to-child transmission. Arch Gynecol Obstet. [DOI: 10.1007/s00404-022-06639-5] [Reference Citation Analysis]
13 Ma L, Ouyang H, Su A, Zhang Y, Pang D, Zhang T, Sun R, Wang W, Xie Z, Lv D. AbSE Workflow: Rapid Identification of the Coding Sequence and Linear Epitope of the Monoclonal Antibody at the Single-cell Level. ACS Synth Biol 2022;11:1856-64. [PMID: 35503752 DOI: 10.1021/acssynbio.2c00018] [Reference Citation Analysis]
14 Acosta-Pérez T, Rodríguez-Yánez T, Almanza-Hurtado A, Martínez-Ávila MC, Dueñas-Castell C. Dynamics of dengue and SARS-COV-2 co-infection in an endemic area of Colombia. Trop Dis Travel Med Vaccines 2022;8:12. [PMID: 35568905 DOI: 10.1186/s40794-022-00169-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
15 Kazachinskaia EI, Shanshin DV, Scherbakov DN, Shestopalov AM. Problematic questions in the development of specific prevention of dengue fever. Med immunol 2022;24:19-30. [DOI: 10.15789/1563-0625-pqi-2346] [Reference Citation Analysis]
16 Prapty CNBS, Rahmat R, Araf Y, Shounak SK, Noor-A-Afrin, Rahaman TI, Hosen MJ, Zheng C, Hossain MG. SARS-CoV-2 and dengue virus co-infection: Epidemiology, pathogenesis, diagnosis, treatment, and management. Rev Med Virol 2023;33:e2340. [PMID: 35238422 DOI: 10.1002/rmv.2340] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
17 Gusev E, Sarapultsev A, Solomatina L, Chereshnev V. SARS-CoV-2-Specific Immune Response and the Pathogenesis of COVID-19. Int J Mol Sci 2022;23:1716. [PMID: 35163638 DOI: 10.3390/ijms23031716] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 21.0] [Reference Citation Analysis]
18 Sattur SS, Sattur IS. COVID-19 Infection: Impact on Hair. Indian J Plast Surg 2021;54:521-6. [PMID: 34984095 DOI: 10.1055/s-0041-1740289] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
19 Bastug A, Bodur H. SARS-CoV-2 Infection and Antibody-Dependent Enhancement. Understanding COVID-19: The Role of Computational Intelligence 2022. [DOI: 10.1007/978-3-030-74761-9_5] [Reference Citation Analysis]
20 Inamadar A. Covid induced telogen effluvium (CITE): An insight. Indian Dermatol Online J 2022;13:445. [DOI: 10.4103/idoj.idoj_139_22] [Reference Citation Analysis]
21 Kolla S, Balleda L, Thimmapuram CR. Effect of severe acute respiratory syndrome coronavirus 2 antibodies on outcomes of dengue infected children: A retrospective observational study. J Pediatr Crit Care 2022;9:80. [DOI: 10.4103/jpcc.jpcc_9_22] [Reference Citation Analysis]
22 Asamoah JKK, Yankson E, Okyere E, Sun G, Jin Z, Jan R, Fatmawati. Optimal control and cost-effectiveness analysis for dengue fever model with asymptomatic and partial immune individuals. Results in Physics 2021;31:104919. [DOI: 10.1016/j.rinp.2021.104919] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
23 Nidom RV, Indrasari S, Normalina I, Nidom AN, Afifah B, Dewi L, Putra AK, Ansori ANM, Kusala MKJ, Alamudi MY, Nidom CA. Phylogenetic and full-length genome mutation analysis of SARS-CoV-2 in Indonesia prior to COVID-19 vaccination program in 2021. Bull Natl Res Cent 2021;45:200. [PMID: 34840498 DOI: 10.1186/s42269-021-00657-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
24 Richardson-Boedler C. Dengue Shock Syndrome: Its Similarity with Anaphylaxis and with the Homeopathic Medicine Apis mellifica (European Honeybee). Homeopathy 2021. [PMID: 34749419 DOI: 10.1055/s-0041-1734027] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
25 Lo Muzio L, Ambosino M, Lo Muzio E, Quadri MFA. SARS-CoV-2 Reinfection Is a New Challenge for the Effectiveness of Global Vaccination Campaign: A Systematic Review of Cases Reported in Literature. Int J Environ Res Public Health 2021;18:11001. [PMID: 34682746 DOI: 10.3390/ijerph182011001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
26 Sánchez-Zuno GA, Matuz-Flores MG, González-Estevez G, Nicoletti F, Turrubiates-Hernández FJ, Mangano K, Muñoz-Valle JF. A review: Antibody-dependent enhancement in COVID-19: The not so friendly side of antibodies. Int J Immunopathol Pharmacol 2021;35:20587384211050199. [PMID: 34632844 DOI: 10.1177/20587384211050199] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 7.0] [Reference Citation Analysis]
27 Silvestre OM, Costa LR, Lopes BVR, Barbosa MR, Botelho KKP, Albuquerque KLC, Souza AGS, Coelho LA, de Oliveira AJ, Barantini CB, Neves SAVM, Nadruz W, Maguire JH, Fernandes-Silva MM. Previous Dengue Infection and Mortality in Coronavirus Disease 2019 (COVID-19). Clin Infect Dis 2021;73:e1219-21. [PMID: 33373433 DOI: 10.1093/cid/ciaa1895] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
28 He X, Ding L, Cao K, Peng H, Gu C, Li Y, Li D, Dong L, Hong X, Wang X, Fu M, Qiu C, Zhu C, Zhang Z, Song S, Wang C, Jiang Z, Xie Y, Qi Z, Zhao C, Zhao P, Zhang X, Xu J. A human cell-based SARS-CoV-2 vaccine elicits potent neutralizing antibody responses and protects mice from SARS-CoV-2 challenge. Emerg Microbes Infect 2021;10:1555-73. [PMID: 34304724 DOI: 10.1080/22221751.2021.1957400] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
29 Yang B, Yang KD. Immunopathogenesis of Different Emerging Viral Infections: Evasion, Fatal Mechanism, and Prevention. Front Immunol 2021;12:690976. [PMID: 34335596 DOI: 10.3389/fimmu.2021.690976] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
30 Rossi A, Magri F, Sernicola A, Michelini S, Caro G, Muscianese M, Di Fraia M, Chello C, Fortuna MC, Grieco T. Telogen Effluvium after SARS-CoV-2 Infection: A Series of Cases and Possible Pathogenetic Mechanisms. Skin Appendage Disord 2021;21:1-5. [PMID: 34373830 DOI: 10.1159/000517223] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
31 Taherkhani R, Taherkhani S, Farshadpour F. Dynamics of host immune responses to SARS-CoV-2. World J Clin Cases 2021; 9(18): 4480-4490 [PMID: 34222416 DOI: 10.12998/wjcc.v9.i18.4480] [Reference Citation Analysis]
32 Mejía-Parra JL, Aguilar-Martinez S, Fernández-Mogollón JL, Luna C, Bonilla-Aldana DK, Rodriguez-Morales AJ, Díaz-Vélez C. Characteristics of patients coinfected with Severe Acute Respiratory Syndrome Coronavirus 2 and dengue virus, Lambayeque, Peru, May-August 2020: A retrospective analysis. Travel Med Infect Dis 2021;43:102132. [PMID: 34186213 DOI: 10.1016/j.tmaid.2021.102132] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
33 Hussman JP. Severe Clinical Worsening in COVID-19 and Potential Mechanisms of Immune-Enhanced Disease. Front Med (Lausanne) 2021;8:637642. [PMID: 34239884 DOI: 10.3389/fmed.2021.637642] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
34 Farshadpour F, Taherkhani R. Antibody-Dependent Enhancement and the Critical Pattern of COVID-19: Possibilities and Considerations. Med Princ Pract 2021. [PMID: 33882487 DOI: 10.1159/000516693] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
35 Rao JS, Matson AW, Taylor RT, Burlak C. Xenotransplantation Literature Update January/February 2021. Xenotransplantation 2021;28:e12685. [PMID: 33884670 DOI: 10.1111/xen.12685] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
36 Nurlu Temel E. Covid-19 Tedavisinde İmmun Plazma Uygulamaları. SDÜ Tıp Fakültesi Dergisi 2021. [DOI: 10.17343/sdutfd.906321] [Reference Citation Analysis]
37 Truc F, Gervino G. The effects of physical distancing and lockdown to restrain SARS-CoV-2 outbreak in the Italian Municipality of Cogne.. [DOI: 10.1101/2021.03.19.21253962] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
38 Kathiravan MK, Radhakrishnan S, Namasivayam V, Palaniappan S. An Overview of Spike Surface Glycoprotein in Severe Acute Respiratory Syndrome-Coronavirus. Front Mol Biosci 2021;8:637550. [PMID: 33898518 DOI: 10.3389/fmolb.2021.637550] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
39 Vanhove B, Duvaux O, Rousse J, Royer PJ, Evanno G, Ciron C, Lheriteau E, Vacher L, Gervois N, Oger R, Jacques Y, Conchon S, Salama A, Duchi R, Lagutina I, Perota A, Delahaut P, Ledure M, Paulus M, So RT, Mok CK, Bruzzone R, Bouillet M, Brouard S, Cozzi E, Galli C, Blanchard D, Bach JM, Soulillou JP. High neutralizing potency of swine glyco-humanized polyclonal antibodies against SARS-CoV-2. Eur J Immunol 2021;51:1412-22. [PMID: 33576494 DOI: 10.1002/eji.202049072] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 5.5] [Reference Citation Analysis]
40 Demarco JK, Severson WE, Demarco DR, Pogue G, Gabbard J, Palmer KE. At the Intersection Between SARS-CoV-2, Macrophages and the Adaptive Immune Response: A Key Role for Antibody-Dependent Pathogenesis But Not Enhancement of Infection in COVID-19.. [DOI: 10.1101/2021.02.22.432407] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
41 Dogan M, Kozhaya L, Placek L, Gunter C, Yigit M, Hardy R, Plassmeyer M, Coatney P, Lillard K, Bukhari Z, Kleinberg M, Hayes C, Arditi M, Klapper E, Merin N, Liang BT, Gupta R, Alpan O, Unutmaz D. SARS-CoV-2 specific antibody and neutralization assays reveal the wide range of the humoral immune response to virus. Commun Biol 2021;4:129. [PMID: 33514825 DOI: 10.1038/s42003-021-01649-6] [Cited by in Crossref: 58] [Cited by in F6Publishing: 66] [Article Influence: 29.0] [Reference Citation Analysis]
42 Martinez OM, Bridges ND, Goldmuntz E, Pascual V. The immune roadmap for understanding multi-system inflammatory syndrome in children: opportunities and challenges. Nat Med 2020;26:1819-24. [PMID: 33139949 DOI: 10.1038/s41591-020-1140-9] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 11.5] [Reference Citation Analysis]
43 Nidom RV, Indrasari S, Normalina I, Nidom AN, Afifah B, Dewi L, Putra AK, Ansori ANM, Kusala MKJ, Alamudi MY, Nidom CA. An Updated Investigation Prior To COVID-19 Vaccination Program In Indonesia: Full-Length Genome Mutation Analysis Of SARS-CoV-2.. [DOI: 10.1101/2021.01.26.426655] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
44 Ortiz López LÁ, Morales León LA, Palazuelos Ramírez DF, Lam Rascón JF, Castillo Díaz LA. Papel de los tejidos orales durante la infección por SARS-CoV-2. Revista de la Asociación Dental Mexicana 2021;78:167-175. [DOI: 10.35366/100075] [Reference Citation Analysis]
45 Wang H, Wang Z, Liu S. Current status and future trends of vaccine development against viral infection and disease. New J Chem 2021;45:7437-7449. [DOI: 10.1039/d1nj00996f] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
46 Lin JE, Asfour A, Sewell TB, Hooe B, Pryce P, Earley C, Shen MY, Kerner-Rossi M, Thakur KT, Vargas WS, Silver WG, Geneslaw AS. Neurological issues in children with COVID-19. Neurosci Lett 2021;743:135567. [PMID: 33352286 DOI: 10.1016/j.neulet.2020.135567] [Cited by in Crossref: 80] [Cited by in F6Publishing: 89] [Article Influence: 26.7] [Reference Citation Analysis]
47 Song X, Hu W, Yu H, Zhao L, Zhao Y, Zhao X, Xue H, Zhao Y. Little to no expression of angiotensin‐converting enzyme‐2 on most human peripheral blood immune cells but highly expressed on tissue macrophages. Cytometry. [DOI: 10.1002/cyto.a.24285] [Cited by in Crossref: 49] [Cited by in F6Publishing: 53] [Article Influence: 16.3] [Reference Citation Analysis]
48 Rawat K, Kumari P, Saha L. COVID-19 vaccine: A recent update in pipeline vaccines, their design and development strategies. Eur J Pharmacol 2021;892:173751. [PMID: 33245898 DOI: 10.1016/j.ejphar.2020.173751] [Cited by in Crossref: 154] [Cited by in F6Publishing: 120] [Article Influence: 51.3] [Reference Citation Analysis]
49 Jain S, Batra H, Yadav P, Chand S. COVID-19 Vaccines Currently under Preclinical and Clinical Studies, and Associated Antiviral Immune Response. Vaccines (Basel) 2020;8. [PMID: 33153096 DOI: 10.3390/vaccines8040649] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 11.0] [Reference Citation Analysis]
50 Vanhove B, Duvaux O, Rousse J, Royer PJ, Evanno G, Ciron C, Lheriteau E, Vacher L, Gervois N, Oger R, Jacques Y, Conchon S, Salama A, Duchi R, Lagutina I, Perota A, Delahaut P, Ledure M, Paulus M, So RT, Mok CK, Bruzzone R, Bouillet M, Brouard S, Cozzi E, Galli C, Blanchard D, Bach JM, Soulillou JP. High neutralizing potency of swine glyco-humanized polyclonal antibodies against SARS-CoV-2. bioRxiv 2020:2020. [PMID: 34013271 DOI: 10.1101/2020.07.25.217158] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
51 Silva TF, Tomiotto-Pellissier F, Sanfelice RA, Gonçalves MD, da Silva Bortoleti BT, Detoni MB, Rodrigues ACJ, Carloto ACM, Concato VM, Siqueira EDS, Costa IN, Pavanelli WR, Conchon-Costa I, Miranda-Sapla MM. A 21st Century Evil: Immunopathology and New Therapies of COVID-19. Front Immunol 2020;11:562264. [PMID: 33193331 DOI: 10.3389/fimmu.2020.562264] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
52 Wibawa T. COVID-19 vaccine research and development: ethical issues. Trop Med Int Health 2021;26:14-9. [PMID: 33012020 DOI: 10.1111/tmi.13503] [Cited by in Crossref: 37] [Cited by in F6Publishing: 43] [Article Influence: 12.3] [Reference Citation Analysis]
53 Dlamini GS, Muller SJ, Meraba RL, Young RA, Mashiyane J, Chiwewe T, Mapiye DS. Classification of COVID-19 and Other Pathogenic Sequences: A Dinucleotide Frequency and Machine Learning Approach. IEEE Access 2020;8:195263-73. [PMID: 34976561 DOI: 10.1109/ACCESS.2020.3031387] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
54 Dogan M, Kozhaya L, Placek L, Gunter CL, Yigit M, Hardy R, Plassmeyer M, Coatney P, Lillard K, Bukhari Z, Kleinberg M, Hayes C, Arditi M, Klapper E, Merin N, Liang BT, Gupta R, Alpan O, Unutmaz D. Novel SARS-CoV-2 specific antibody and neutralization assays reveal wide range of humoral immune response during COVID-19. medRxiv 2020:2020. [PMID: 32676617 DOI: 10.1101/2020.07.07.20148106] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
55 Shao S, Wang Y, Kang H, Tong Z. Effect of convalescent blood products for patients with severe acute respiratory infections of viral etiology: A systematic review and meta-analysis. Int J Infect Dis. 2021;102:397-411. [PMID: 33002611 DOI: 10.1016/j.ijid.2020.09.1443] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
56 Harapan H, Ryan M, Yohan B, Abidin RS, Nainu F, Rakib A, Jahan I, Emran TB, Ullah I, Panta K, Dhama K, Sasmono RT. Covid-19 and dengue: Double punches for dengue-endemic countries in Asia. Rev Med Virol 2021;31:e2161. [PMID: 32946149 DOI: 10.1002/rmv.2161] [Cited by in Crossref: 64] [Cited by in F6Publishing: 71] [Article Influence: 21.3] [Reference Citation Analysis]
57 Xi Y. Convalescent plasma therapy for COVID-19: a tried-and-true old strategy? Signal Transduct Target Ther 2020;5:203. [PMID: 32934211 DOI: 10.1038/s41392-020-00310-8] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 7.7] [Reference Citation Analysis]
58 Munoz Mendoza J, Alcaide ML. COVID-19 in a patient with end-stage renal disease on chronic in-center hemodialysis after evidence of SARS-CoV-2 IgG antibodies. Reinfection or inaccuracy of antibody testing. IDCases 2020;22:e00943. [PMID: 32923364 DOI: 10.1016/j.idcr.2020.e00943] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 5.7] [Reference Citation Analysis]
59 Samrat SK, Tharappel AM, Li Z, Li H. Prospect of SARS-CoV-2 spike protein: Potential role in vaccine and therapeutic development. Virus Res 2020;288:198141. [PMID: 32846196 DOI: 10.1016/j.virusres.2020.198141] [Cited by in Crossref: 75] [Cited by in F6Publishing: 80] [Article Influence: 25.0] [Reference Citation Analysis]
60 Pillat MM, Krüger A, Guimarães LMF, Lameu C, de Souza EE, Wrenger C, Ulrich H. Insights in Chloroquine Action: Perspectives and Implications in Malaria and COVID-19. Cytometry A 2020;97:872-81. [PMID: 32686260 DOI: 10.1002/cyto.a.24190] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
61 Zheng Y, Yan M, Wang L, Luan L, Liu J, Tian X, Wan N. Analysis of the application value of serum antibody detection for staging of COVID-19 infection. J Med Virol 2021;93:899-906. [PMID: 32779744 DOI: 10.1002/jmv.26330] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
62 Das CS. Acute Respiratory Ailments in Pediatric Age Group and Role of CRP in Diagnosis and Management. Clinical Significance of C-reactive Protein 2020. [DOI: 10.1007/978-981-15-6787-2_8] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
63 [DOI: 10.1101/2020.08.06.238915] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Reference Citation Analysis]